Associated Papers
Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease.
Panda SP et al.
Neuroscience, 2026
Autophagy and mitophagy at the synapse and beyond: implications for learning, memory and neurological disorders.
Lu J et al.
Autophagy, 2026
The Christchurch point mutation in mouse APOE reduces Aβ-induced tau and α-synuclein pathologies.
Soto-Faguás CM et al.
Biorxiv : the Preprint Server for Biology, 2025
Protein aggregation in neurodegenerative diseases.
Wang J et al.
Chinese Medical Journal, 2025
Hemoglobin as a pseudoperoxidase and drug target for oxidative stress-related diseases.
Won W et al.
Signal Transduction and Targeted Therapy, 2025
Insights Into Retinal Pathologies in Neurological Disorders: A Focus on Parkinson's Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer's Disease.
Akyuz E et al.
Journal of Neuroscience Research, 2025
Mechanism and Clinical Application Prospects of Mitochondrial DNA Single Nucleotide Polymorphism in Neurodegenerative Diseases.
Xu M et al.
Neurochemical Research, 2024
Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders.
Sidoryk-Węgrzynowicz M et al.
International Journal of Molecular Sciences, 2024
Gene replacement-Alzheimer's disease (GR-AD): Modeling the genetics of human dementias in mice.
Benzow K et al.
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2024
Gangliosides as Therapeutic Targets for Neurodegenerative Diseases.
Inci OK et al.
Journal of Lipids, 2024
Role of Autophagy Pathway in Parkinson's Disease and Related Genetic Neurological Disorders.
Themistokleous C et al.
Journal of Molecular Biology, 2023
Interaction Between the Glymphatic System and α-Synuclein in Parkinson's Disease.
Zhang Y et al.
Molecular Neurobiology, 2023
Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation.
Calabrese G et al.
The Journal of Biological Chemistry, 2022
Role of lysosomes in physiological activities, diseases, and therapy.
Zhang Z et al.
Journal of Hematology & Oncology, 2021
Therapeutic Potential of Vital Transcription Factors in Alzheimer's and Parkinson's Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy.
Rai SN et al.
Frontiers in Neuroscience, 2021
The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.
Hwang J et al.
International Journal of Molecular Sciences, 2019
Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms.
Oksanen M et al.
Cellular and Molecular Life Sciences : Cmls, 2019
Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention.
Briston T et al.
Biochemical Society Transactions, 2018
Autonomic dysfunction in genetic forms of synucleinopathies.
Chelban V et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2018
Molecular Genetics of Neurodegenerative Dementias.
Hinz FI et al.
Cold Spring Harbor Perspectives in Biology, 2017
Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation.
Huang Y et al.
Translational Neurodegeneration, 2012
Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders.
Marks N et al.
Neurochemistry International, 2008
Autosomal dominant Parkinson's disease and the route to new therapies.
Morris HR
Expert Review of Neurotherapeutics, 2007
Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms.
Forloni G et al.
Neurobiology of Aging, 0